<VariationArchive VariationID="3247244" VariationName="NC_000002.11:g.(?_228552862)_(228553043_?)del" VariationType="Deletion" Accession="VCV003247244" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3405703" VariationID="3247244">
      <GeneList>
        <Gene Symbol="SLC19A3" FullName="solute carrier family 19 member 3" GeneID="80704" HGNC_ID="HGNC:16266" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227683763" stop="227718028" display_start="227683763" display_stop="227718028" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="228549925" stop="228582744" display_start="228549925" display_stop="228582744" Strand="-" />
          </Location>
          <OMIM>606152</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_228552862)_(228553043_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="228552862" innerStop="228553043" display_start="228552862" display_stop="228553043" variantLength="182" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_228552862)_(228553043_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_228552862)_(228553043_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_228552862)_(228553043_?)del AND Biotin-responsive basal ganglia disease" Accession="RCV004582530" Version="1">
        <ClassifiedConditionList TraitSetID="1254">
          <ClassifiedCondition DB="MedGen" ID="C1843807">Biotin-responsive basal ganglia disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23482991</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24372704</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1254" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="585" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Biotin-thiamine-responsive basal ganglia disease</ElementValue>
                <XRef ID="Basal+Ganglia+Disease%2C+Biotin-Responsive/756" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Biotin-responsive basal ganglia disease</ElementValue>
                <XRef ID="MONDO:0011841" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine metabolism dysfunction syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">thiamine-responsive encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thiamine Transporter-2 Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- AND THIAMINE-RESPONSIVE TYPE)</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">THMD2</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BBGD</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BBTGD</ElementValue>
                <XRef Type="MIM" ID="607483" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10237" />
                <XRef ID="10237" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Biotin-thiamine-responsive basal ganglia disease (BTBGD) may present in childhood, early infancy, or adulthood. The classic presentation of BTBGD occurs in childhood (age 3-10 years) and is characterized by recurrent subacute encephalopathy manifest as confusion, seizures, ataxia, dystonia, supranuclear facial palsy, external ophthalmoplegia, and/or dysphagia which, if left untreated, can eventually lead to coma and even death. Dystonia and cogwheel rigidity are nearly always present; hyperreflexia, ankle clonus, and Babinski responses are common. Hemiparesis or quadriparesis may be seen. Episodes are often triggered by febrile illness or mild trauma or stress. Simple partial or generalized seizures are easily controlled with anti-seizure medication. An early-infantile Leigh-like syndrome / atypical infantile spasms presentation occurs in the first three months of life with poor feeding, vomiting, acute encephalopathy, and severe lactic acidosis. An adult-onset Wernicke-like encephalopathy presentation is characterized by acute onset of status epilepticus, ataxia, nystagmus, diplopia, and ophthalmoplegia in the second decade of life. Prompt administration of biotin and thiamine early in the disease course results in partial or complete improvement within days in the childhood and adult presentations, but most with the infantile presentation have had poor outcome even after supplementation with biotin and thiamine.</Attribute>
                <XRef ID="NBK169615" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24260777</ID>
                <ID Source="BookShelf">NBK169615</ID>
              </Citation>
              <XRef ID="199348" DB="Orphanet" />
              <XRef ID="65284" DB="Orphanet" />
              <XRef ID="C1843807" DB="MedGen" />
              <XRef ID="MONDO:0011841" DB="MONDO" />
              <XRef Type="MIM" ID="607483" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9837781" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000002.11:g.(?_228552862)_(228553043_?)del|MedGen:C1843807" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005067891" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23482991</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24372704</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 5 of the SLC19A3 gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein. A similar copy number variant has been observed in individual(s) with SLC19A3-related conditions (PMID: 23482991, 24372704). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as p.Q393*fs. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_228552862)_(228553043_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1843807" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9837781" TraitType="Disease" MappingType="XRef" MappingValue="C1843807" MappingRef="MedGen">
        <MedGen CUI="C1843807" Name="Biotin-responsive basal ganglia disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

